ENTRADA THERAPEUTICS INC shareholders Q3 2023

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BlackRock Inc. 1,404,403$22,189,5680.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 56,149$887,1540.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,679$168,7280.00%
FMR LLC 582,116$9,197,4330.00%
MetLife Investment Management, LLC 11,694$184,7650.00%
GEODE CAPITAL MANAGEMENT, LLC 438,581$6,930,3720.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,212$19,1500.00%
Nuveen Asset Management, LLC 73,362$1,159,1200.00%
Bank of New York Mellon Corp 66,953$1,057,8580.00%
AMALGAMATED BANK 2,081$330.00%
Tower Research Capital LLC (TRC) 1,003$15,8470.00%
Allspring Global Investments Holdings, LLC 2,798$44,2080.00%
JPMORGAN CHASE & CO 14,581$230,3800.00%
BARCLAYS PLC 5,932$940.00%
ROYAL BANK OF CANADA 3,724$59,0000.00%
VANGUARD GROUP INC 1,020,317$16,121,0090.00%
Mirae Asset Global Investments Co., Ltd. 10,874$171,8090.00%
Swiss National Bank 25,200$398,1600.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 15,007$237,1110.00%
UBS Group AG 13,311$210,3140.00%

This page lists ENTRADA THERAPEUTICS INC's shareholders in Q3 2023. To view ENTRADA THERAPEUTICS INC's shareholder history, click here.